FIELD: organic chemistry. SUBSTANCE: invention relates to tetrazole derivatives of the general formula: where: A - alkylene group with 1-4 carbon atoms; R1 - hydrogen or lower alkyl-group; R2 - hydrogen, hydroxy, halide, carboxy-C1-7-alkyl, amido, amino, C1-7-alkoxy, phenyl, phenylhydroxy, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, nitro-group or group of the formula: -NHCOCOO-R5 where R5- - hydrogen or lower alkyl, mono- or di-(lower)-alkylaminosulfonyl or group of the formula: (I) where A and R1 as indicated above; R3 - hydrogen, halide, nitro, C1-7-alkyl, C1-7-alkoxy or hydroxy; R4- - hydrogen, C1-7-alkyl, C1-7-alkoxy or group -NHCOCOO-R3 where R5 as indicated above at condition that compound of the formula (I) does not involve the following combination of substituents; where A - methylene group, R2,R3 and R4 - hydrogen atoms and R1 - hydrogen atom, methyl group or ethyl group; where A - ethylidene group, R2,R3 and R4 - hydrogen atoms and R1- - hydrogen atom or ethyl group; where A - isopropylidene group, R2,R3 and R4 - hydrogen atoms and R1- - hydrogen atom or ethyl group; where A - methylene group, R2- - 4-bromo, 3- or 4-chloro, 3- or 4-methyl, 3- or 4-nitro, or 3-trifluoromethyl group; R3 and R4 - hydrogen atoms and R1 - hydrogen atom or ethyl group; and where A - ethylene group, R2,R3 and R4 - hydrogen atoms and R1- - hydrogen atom or ethyl group. Compound is synthesized by chlorination of compound of the general formula (II): where - lower alkyl and the synthesized compound (III) is subjected for interaction with sodium azide. Transformation of radical R1 is possible. The described compounds were used at effective amount in pharmaceutical composition inhibiting aldose reductase activity and they were used as drugs at diabetic complications in medicine. EFFECT: improved method of synthesis. 3 cl, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
CYCLOPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2108342C1 |
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1990 |
|
RU2021990C1 |
METHOD OF SYNTHESIS OF ALKANESULFONANILIDE DERIVATIVES OR THEIRS PHARMACEUTICALLY ACCEPTABLE SALTS | 1988 |
|
RU2012557C1 |
PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2128172C1 |
ETHANOLAMINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1993 |
|
RU2125983C1 |
DERIVATIVES OF N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE AS ANTAGONISTS OF PLATELET ACTIVATION FACTOR, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT | 1994 |
|
RU2161155C2 |
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS | 1994 |
|
RU2176640C2 |
ANTIBIOTIC COMPOSITION | 1988 |
|
RU2029549C1 |
GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS | 1994 |
|
RU2141946C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DISEASE TREATMENT INTERMEDIARY AGENT OF THAT IS TACHIKININ | 1991 |
|
RU2073683C1 |
Authors
Dates
1997-11-27—Published
1990-03-23—Filed